3rd Quarter - Report — HUMANA, INC. for HUMANA INC (2019)

Firm

HUMANA, INC.

Client

HUMANA INC

Income

—

Expenses

$1,900,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Tricare Issues NDAA Implementation Issues H.R. 2500/S. 1790 National Defense Authorization Act of 2020

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2500 (116th), S. 1790 (116th)

Taxation/Internal Revenue Code TAX

H.R. 1398/S. 172 - Health Insurance Tax Relief Act H.R. 2447/S. 80 - Jobs and Premium Protection Act Tax Reform Implementation Issues

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: SENATE; Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 1398 (116th), H.R. 2447 (116th), S. 172 (116th), S. 80 (116th)

Health Issues HCR

H.R. 1398/S. 172 - Health Insurance Tax Relief Act CMS-9115-P Interoperability and Patient Access Proposed Rule HHS ONC RIN-0955-AA01 -- 21st Century Cures Interoperability and Information Blocking Proposed Rule Senate HELP - Lower Health Care Costs Act S. 340/H.R. 965 CREATES Act H.R. 3630, No Surprises Act H.R. 2296, Fair Accountability and Innovative Research Act H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability, and Reporting Act H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act S. 1280/H.R. 2477, BENES Act H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Reduction Act of 2019

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); White House Office

Bills named: H.R. 3630 (116th), S. 172 (116th), S. 2543 (116th), H.R. 2296 (116th), S. 1280 (116th), H.R. 987 (116th), H.R. 965 (116th), S. 340 (116th), H.R. 2113 (116th), H.R. 3 (116th), H.R. 1398 (116th), H.R. 2477 (116th)

Medicare/Medicaid MMM

Medicare Advantage Policy and Reimbursement 2021 Medicare Advantage Advance Rate Notice and Draft Call Letter Medicare Part D Issues CMS-4180-P Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce CMS 4185-P Policy and Technical Changes in Medicare Advantage Program for 2020/2021 Medicaid and Dual Eligible Issues Pharmacy Reimbursement Issues

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: SENATE; Treasury, Dept of; White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.